
|Articles|September 1, 1997
Supplements and Featured Publications
- The Treatment of Hypercholesterolemia: A Managed Care Perspective
- Volume 3
- Issue 8 Suppl
Preventing Coronary Heart Disease in the Managed Care Era: Improving the Cost Effectiveness of Lipid-Lowering Therapy with HMG-CoA Reductase Inhibitors
Author(s)Terry A. Jacobson, MD
Advertisement
Articles in this issue
over 28 years ago
Goals and Objectivesover 28 years ago
Introductionover 28 years ago
The Rationale for Treating Hypercholesterolemiaover 28 years ago
Managing Comorbidities through Cholesterol-Loweringover 28 years ago
CME Quizover 28 years ago
Selected Abstractsover 28 years ago
Bibliographyover 28 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
3
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5














































